{"filings":[{"id":91644,"accession_number":"0001437749-26-015921","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q1 revenue $86.3M, flat YoY; reaffirms pending $26.25/share acquisition by IKS Health","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total bookings $17.7M vs $17.3M; revenue $86.3M vs $87.2M; recurring revenue 94%.","GAAP net income $0.5M (flat YoY); Non-GAAP net income $8.5M vs $5.2M.","Adjusted EBITDA $16.5M vs $18.2M, down 9.3%.","Acquisition by IKS Health at $26.25/share cash; expected close Q3 2026, subject to approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":86271000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91643,"accession_number":"0001193125-26-172139","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["1.01","7.01","5.02","9.01"],"status":"ready","headline":"TruBridge to be acquired by IKS Health for $26.25/share in cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Per share cash consideration of $26.25; support agreements cover ~27% of outstanding TruBridge common stock.","Deal expected to close by October 23, 2026, subject to stockholder vote, HSR clearance, and other conditions.","Reverse termination fee of $24.6M payable to TruBridge if IKS fails to obtain Indian shareholder approval for debt financing.","TruBridge termination fee set at $12.3M if it accepts a superior proposal or changes board recommendation.","Combined entity to leverage AI and IKS Health's care enablement platform to serve rural and community hospitals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101867,"accession_number":"0001437749-26-010657","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q4 revenue $87.2M, full-year GAAP net income $4.4M; engages strategic review","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $87.2M (down 1% YoY); bookings $19.8M (+38% YoY); recurring revenue 94%.","Full-year GAAP net income $4.4M vs loss of $20.9M; non-GAAP net income $38.5M vs $4.6M.","Board launches strategic review of alternatives including sale, JV, share repurchases; no deal assured.","Immaterial revisions to prior financials (2023-2024, interim 2025) for revenue recognition & software costs."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":86271000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101866,"accession_number":"0001193125-26-007672","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"TruBridge appoints Pinetree President Damien Leonard to board; three directors to retire by 2027","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Damien Leonard (Pinetree President) joins TruBridge Board Jan 12; board expands to 10, then shrinks to 7 after 2026 annual meeting.","David Dye (24-year director) not standing for reelection; two other long-serving directors to retire at 2026 annual meeting.","One more director to retire at 2027 annual meeting; Pinetree may suggest a replacement, but Board has no obligation.","Pinetree agrees to standstill (ownership capped at 20%), vote with Board on most items, and mutual non-disparagement.","Leonard will waive director fees; expected to join Compensation Committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118203,"accession_number":"0001193125-25-303161","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"TruBridge refinances credit facilities; revolver capacity up to $180M, term loan to $70M, maturity extended to Nov 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolver capacity increased to $180M (from $160M); term loan outstanding now $70M (up from $54M).","Maturity extended to November 2030 (from May 2027); total outstanding after execution $168M.","Leverage covenant max 3.75x through Sept 2026, then 3.50x thereafter; fixed charge coverage min 1.25x.","EBITDA add-back definitions expanded to include restructuring, integration, and non-recurring expenses.","Prepayment obligation from equity issuances removed; foreign person representation and covenant added."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118202,"accession_number":"0001437749-25-033614","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q3 2025: Revenue $86.1M, GAAP net income $5.6M, Adj EBITDA $16.3M, raises guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $86.1M, up 1.7% YoY; recurring revenue 94% of total; Financial Health segment $54.5M (63% of revenue).","GAAP net income $5.6M vs net loss of $9.1M a year ago; non-GAAP net income $12.8M vs loss of $3.1M.","Adjusted EBITDA $16.3M (19% margin) vs $14.7M; bookings $15.5M vs $21.0M in Q3 2024.","Full-year 2025 guidance raised: revenue $345M–$348M, Adj EBITDA $65M–$68M; Q4 revenue $86M–$89M.","New Chief Business Officer and head of India operations hired to drive growth and offshore transition."],"consensus_eps_estimate":null,"consensus_eps_actual":0.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":259043000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118201,"accession_number":"0001193125-25-229309","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"TruBridge: CSO Dawn Severance to depart Oct 31; Michael Daughton hired as Chief Business Officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CSO Dawn Severance will leave Oct 31, 2025; position eliminated; no disagreement cited.","Severance receives 12 months base salary & target bonus, plus benefits continuation and prorated equity vesting.","Michael Daughton appointed Chief Business Officer effective Oct 6, 2025, reporting to CEO Chris Fowler.","Daughton has 30 years healthcare experience, previously at M*Modal/AQuity, Optum, EnableComp."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134640,"accession_number":"0001437749-25-025532","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q2 2025: GAAP net income $2.6M vs loss $4.4M; raises Adj EBITDA guidance, lowers revenue outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $85.7M flat YoY; recurring revenue 95%. Financial Health segment $54.3M.","GAAP net income $2.6M vs net loss $4.4M YoY; Non-GAAP net income $7.9M vs $3.0M.","Adj EBITDA $13.7M vs $13.4M; FY 2025 Adj EBITDA guidance raised to $62-67M from $60-66M.","FY 2025 revenue guidance lowered to $345-350M from $345-360M; Q3 rev $85-87M.","Total bookings $25.6M vs $23.3M YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":172937000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134639,"accession_number":"0001193125-25-154014","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-07-01T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"TruBridge dismisses Grant Thornton, appoints KPMG; prior adverse internal control opinions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit Committee dismissed Grant Thornton LLP as auditor, effective June 25, 2025.","Grant Thornton's internal control reports for FY2023 and FY2024 each contained adverse opinions over material weaknesses.","No disagreements between TruBridge and Grant Thornton on accounting principles or practices.","Audit Committee engaged KPMG LLP as new independent registered public accounting firm for FY2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151527,"accession_number":"0001193125-25-115975","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"TruBridge shareholders approve board declassification and incentive plan increase at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved declassification of Board, effective 2026 annual meeting; filed with Delaware on May 8, 2025.","Second Amended and Restated 2019 Incentive Plan approved, adding 1,850,000 shares of common stock for issuance.","All four Class II director nominees re-elected: Jerry G. Canada, Christopher L. Fowler, Amy K. O'Keefe, Andris Upitis.","Advisory vote on executive compensation passed with 8,769,664 votes for; ratification of Grant Thornton LLP as auditor approved.","Broker non-votes of 1,922,331 on all director elections and most proposals; auditor ratification had no broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151526,"accession_number":"0001437749-25-015133","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q1 beats with $87.2M revenue & $18.2M adj. EBITDA; raises FY outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $87.2M grew 3.7% YoY; GAAP net income $0.5M vs. $1.9M loss; non-GAAP net income $5.2M vs. $3.4M.","Adjusted EBITDA $18.2M (up 77% YoY); total bookings $22.0M vs. $23.6M, now reported on annual contract value basis.","Financial Health segment revenue $56.1M (64% of total); recurring revenue 94% of total revenue.","FY 2025 revenue guidance unchanged at $345-360M; adj. EBITDA guidance raised to $60-66M from $59-66M.","Leverage ratio reduced to 2.4x; Company appointed Merideth Wilson as GM of Financial Health unit."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":87208000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170396,"accession_number":"0001193125-25-055820","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K/A","filed_at":"2025-03-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge corrects revenue error, revises FY2024 net loss to -$20.4M from -$23.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue for FY24 revised up $3.5M to $342.6M; FY23 revised down $3.5M to $335.9M.","Net loss for FY24 revised to $20.4M ($1.38 loss per diluted share) from $23.1M ($1.55 loss).","Financial Health segment revenue FY24 $217.7M; Patient Care revenue $125.0M.","Accounting error had no cash flow impact; company deemed error not material to prior periods.","Company reiterates 2025 outlook, no specific guidance provided in corrected release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170399,"accession_number":"0001437749-25-006839","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge reports FY2024 revenue $339.2M, net loss $23.1M; issues FY2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $87.4M (up 1.7% YoY); adjusted EBITDA $17.2M vs $12.0M YoY.","Full-year 2024 adjusted EBITDA $53.1M (up 11.5% YoY); net loss $23.1M vs $33.2M loss in 2023.","Financial Health segment revenue $216.1M (up 11.5% YoY), 63.7% of total; recurring revenue 94.4%.","Debt repayment reduced leverage ratio from 4x to ~3x YoY; divested AHT business.","FY2025 revenue guidance $345-360M, adjusted EBITDA $59-66M; Q1 2025 rev $85-88M, adj. EBITDA $14-16M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170398,"accession_number":"0001193125-25-024808","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["1.01","3.03","5.02","7.01","9.01"],"status":"ready","headline":"TruBridge adds two directors, declassifies board in cooperation deal with top investors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Appointed Jerry Canada (former Group President, Harris Computer Healthcare) and Dris Upitis (Head of Ocho) as independent Class II directors, increasing board from 7 to 9.","Board declassification proposal to be voted at 2025 annual meeting; if approved, all directors will serve one-year terms starting in 2026.","Company terminated its stockholder rights plan effective 5:00 PM ET on Feb 12, 2025, as part of cooperation agreements with Pinetree and Ocho.","David Dye will not stand for reelection at the 2026 annual meeting; departure not due to any disagreement with the Company.","Pinetree and Ocho, the two largest investors, agreed to standstill, voting, and information-sharing provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170397,"accession_number":"0001193125-25-000145","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2025-01-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"TruBridge COO David A. Dye departs effective Dec 31, 2024; receives severance package","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David A. Dye ceases as Chief Operating Officer effective December 31, 2024.","Severance includes 18-month installment payments equal to 1.5x sum of base salary and target bonus for 2024.","Up to 18 months of medical/dental continuation coverage reimbursement included.","Unvested restricted stock continues vesting during non-compete; pro-rated cash incentive and performance share awards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187389,"accession_number":"0001437749-24-033988","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"TruBridge Q3 revenue $83.8M, bookings $21M; COO David Dye retiring","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $83.8M vs $82.7M YoY; bookings $21.0M (up 40% from $15.0M).","GAAP net loss $(9.8)M ($(0.66)/share); non-GAAP net loss $(3.0)M ($(0.21)/share).","Adjusted EBITDA $13.8M (16.5% margin) vs $9.7M in prior year.","COO David Dye retiring Dec 31, 2024; position eliminated; business unit GMs now report to CEO.","FY2024 revenue guidance narrowed to $335-$337M; adj. EBITDA $49-$50M (previously $45-$50M)."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":251806000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187388,"accession_number":"0001193125-24-244163","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-10-25T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"TruBridge amends bylaws to update proxy card rules, definitions, and officer duties","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved Second Amended and Restated Bylaws effective October 25, 2024.","Stockholders soliciting proxies must now use a proxy card color other than white.","Definitions of 'stockholder associated person' and 'nominating stockholder associated person' narrowed.","Powers and duties of certain officers clarified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187387,"accession_number":"0001193125-24-240254","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-10-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"TruBridge appoints Amy O'Keefe to board, replacing Denise Warren effective Nov 15, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Denise Warren resigns from TruBridge board effective Nov 15, 2024 to become chair of Brookdale Senior Living (NYSE: BKD).","Amy O'Keefe elected to board effective Oct 18, 2024, filling Warren's seat as Class II director until 2025 annual meeting.","O'Keefe currently serves as CFO of Avaya and has prior experience at WW International, Stanley Black & Decker, and Ernst & Young.","O'Keefe appointed to Audit Committee; board determined she is independent under Nasdaq rules.","Warren's resignation not due to any disagreement with company operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203885,"accession_number":"0001437749-24-025583","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q2 revenue flat at $84.7M, adjusted EBITDA up to $12.6M, reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $84.7M vs $84.6M; RCM revenue grew 13% to $54.1M (63.9% of total).","GAAP diluted EPS loss $(0.34) vs $(0.20); Non-GAAP EPS $0.16 vs $0.40.","Adjusted EBITDA $12.6M vs $11.2M; total bookings $23.3M vs $21.0M.","Q3 guidance: rev $82-85M, adj EBITDA $11.5-13.5M; FY24 reaffirmed: rev $330-340M, adj EBITDA $45-50M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":167977000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220513,"accession_number":"0001193125-24-137255","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"TruBridge stockholders re-elect directors, approve say-on-pay and auditor at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class I directors Mark V. Anquillare and Glenn P. Tobin re-elected to serve until 2027.","Advisory vote on executive compensation passed with 8,729,095 for, 1,665,632 against.","Grant Thornton LLP ratified as independent auditor for FY2024 with 10,662,354 votes for.","Broker non-votes: 1,342,126 on proposals 1 and 2."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220512,"accession_number":"0001437749-24-015810","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"TruBridge Q1: GAAP loss of $0.17/share; FY2024 revenue guidance lowered","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $83.2M (-3.5% YoY); RCM revenue grew to $53.0M (63.7% of total).","GAAP diluted loss per share $(0.17) vs $0.21 EPS; Non-GAAP EPS $0.19 vs $0.58.","Adjusted EBITDA $9.5M, down from $14.6M; bookings rose to $23.6M from $19.8M.","Full-year 2024 revenue guidance cut to $330M-$340M from $340M-$350M; Adj EBITDA unchanged $45M-$50M.","Q2 2024 revenue guided $81M-$83M; Adj EBITDA $8M-$10M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":83247000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220511,"accession_number":"0001193125-24-106024","cik":1169445,"company_name":"TruBridge, Inc.","ticker":"TBRG","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["1.01","3.03","7.01","9.01"],"status":"ready","headline":"TruBridge amends poison pill, raises triggering threshold to 15% from 10% after stockholder input","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved amendment to Rights Plan increasing beneficial ownership threshold from 10% to 15%.","Rights become exercisable if a person/group acquires 15%+ of common stock without Board approval.","All other terms unchanged; Rights Plan expires March 25, 2025.","Amendment follows stockholder engagement and feedback from governance professionals.","Board retains ability to redeem rights for $0.001 per right at any time prior to triggering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":389227590.00000006,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}